Our Team

Mark David

Director Discovery of Product Development. Senior Clinical Scientist

Dr. David is a senior (clinical) scientist with a PhD from Imperial College of London and over 20 years of experience spanning industry and academia. He specializes in small molecule bioanalysis, with a focus on developing and optimizing analytical and bioinformatic workflows for LC-MS-based metabolomics and lipidomics applications. His expertise extends to research, analytical method validation, and knowledge of quality management systems. In addition to his scientific contributions, Dr. David serves as a technical assessor for NATA, ensuring compliance with industry standards.

Meet the rest of our team
Board of Directors
Leadership Team
Scientific Advisors
Clinical Studies Team
Other Key Members

Jayne Shaw

Co-Founder and Executive Chair

The Hon Ron Phillips (AO)

Co-founder

Dr John Hurrell

Non-Executive Director and Consultant

Jonathan Trollip

Independent Non-Executive Director

David Darling

Non-Executive Director

Mark Burrows AO

Independent Non-Executive Director

Shane Ryan

Chief Executive Officer

Kathy Koskiris

Director of Clinical Laboratory Services

Guy Robertson

Chief Financial Officer & Company Secretary

Dr Simon Preston

Director Clinical Research

Alexandra Feetham

Head of Innovation

Kim Kirkham

National Clinical Program Director

Tanya Thomas

Director Investor Relations & Communications

Klaus-Peter Adam

Director of US Research & Product

Kalpesh Shah

Medical Laboratory Scientist

Dr David Peak, PhD

USA Scientific Lead, Technology Transfer

Dr Simon Preston

Director Clinical Research

Klaus-Peter Adam

Director of US Research & Product

Leinad Diaz

Research Scientist

Dr Simon Preston

Director Clinical Research

Lisa Ren

Clinical Research Lead

Tim Huang

Data Analyst

Hardik Patel

Quality Co-Ordinator

Cory Dunn

US Commercial Operations

Ella Makovec

Program Co-Ordinator

Kate Heaney

Receipt & Accessing Officer

Rebecca Shaw

Head of Webpage Development
crossmenuarrow-left